Programmed cell death ligand 1 (PD-L1) expression in non-small cell lung cancer: Findings from a tertiary care institute in western part of India

Priyank Jain,Nishant Kumar Chauhan,Amartya Chakraborti,Manoj Kumar Gupta,Naveen Dutt,Ram Niwas Jalandra,Poonam Elhence,Meenakshi Rao,Pushpinder Khera,Pawan Kumar Garg,Puneet Pareek,Jeewan Ram Vishnoi,Sanjeev Misra

Indian Journal of Tuberculosis（2023）

引用 0|浏览4

暂无评分

摘要

•This study looks at the relationship between PD-L1 expression and clinico–radiologic parameters of NSCLC patients.•Subjectivity in PD-L1 IHC reporting was minimized by getting the analysis done by two pathologists.•Our findings lay foundation for a large multicentric study in India on PD-L1 expression in advanced NSCLC patients.

查看译文

关键词

Clinical,Histologic,Immunotherapy,Lung cancer,Programmed cell death ligand 1

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要